MedTrace Logo

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

NCT05919277 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1487

Last updated 2023-09-13

No results posted yet for this study

Summary

The objective of this observational study of dengue seroprevalence in the metropolitan area of Buenos Aires is to know what percentage of the population has antibodies against dengue in persons 18 years of age or older who are residents of the city of Buenos Aires or its metropolitan area. The main questions to be answered are:

* What is the seroprevalence of antibodies against dengue measured by Immunoglobulin G determination by ELISA
* Characterize the different dengue serotypes in the affected population. Participants will undergo a small blood draw to determine the presence of Immunoglobulin G antibodies against dengue.
* Tests will also be performed to determine infection by flaviviruses other than dengue virus.

Conditions

  • Dengue
  • Flavivirus Infections

Interventions

DIAGNOSTIC_TEST

Dengue Immunoglobulin G antibodies performed with ELISA

All participants who agree to participate by signing an informed consent form will undergo a finger prick for the determination of Immunoglobulin G antibodies measured by ELISA. In a subgroup of persons who test positive, they will be invited to have blood drawn for neutralization determination in order to study serotypes and the presence of other flaviviruses.

Sponsors & Collaborators

Principal Investigators

  • Alejandro Macchia, MD · Fundacion GESICA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-11
Primary Completion
2023-12-31
Completion
2024-09-30

Countries

  • Argentina

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05919277 on ClinicalTrials.gov